Igene Biotechnology, Inc. (IGNE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2009 | 2008 | 2007 | 2006 | 2003 | 2002 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -97.04 Thousand | 705.61 Thousand | 1.31 Million | 100.00 | -173.61 Thousand | -1.31 Million |
| Net Income | -140.74 Thousand | -3.99 Million | -1.89 Million | -1.15 Million | -2.19 Million | -3.18 Million |
| Depreciation & Amortization | 150.72 Thousand | 107.82 Thousand | 12.43 Thousand | 16.48 Thousand | 83.78 Thousand | 177.42 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.09 Million | 7.34 Million | 1.66 Million | 941.57 Thousand | 1.08 Million | 1.33 Million |
| Other non-cash items | -2.2 Million | -2.76 Million | 1.53 Million | 197.81 Thousand | 858.87 Thousand | 368.03 Thousand |
| Investing Cash Flow | -171.77 Thousand | -226.16 Thousand | -362.9 Thousand | -109.14 Thousand | -10.22 Thousand | -136.95 Thousand |
| Investments in PPE | -171.77 Thousand | -226.16 Thousand | -275.08 Thousand | - | - | -100.15 Thousand |
| Acquisitions | - | - | -107.82 Thousand | -109.14 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 20 Thousand | - | -10.22 Thousand | -36.79 Thousand |
| Financing Cash Flow | - | - | 57 Thousand | 11.08 Thousand | -250.79 Thousand | 1.55 Million |
| Debt repayment | - | - | -705 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 2500.00 | - |
| Other Financing Activities | - | - | 762 Thousand | - | -253.29 Thousand | - |
| Accounts receivables | 1.04 Million | 1.67 Million | -3.69 Million | 14.61 Thousand | - | - |
| Accounts payables | - | -4.31 Million | - | - | - | - |
| Inventory | 2.39 Million | 5.66 Million | 1.81 Million | - | 374.7 Thousand | 352.36 Thousand |
| Other working capital | -1.34 Million | 14.64 Thousand | 3.54 Million | 926.95 Thousand | 708.15 Thousand | 979.26 Thousand |
| Cash at beginning of period | 1.48 Million | 1.02 Million | 21.78 Thousand | 119.74 Thousand | 497.71 Thousand | 394.48 Thousand |
| Cash at end of period | 1.29 Million | 1.48 Million | 1.02 Million | 21.78 Thousand | 63.07 Thousand | 497.71 Thousand |
| Capital Expenditure | -171.77 Thousand | -226.16 Thousand | -275.08 Thousand | - | - | -100.15 Thousand |
| Effect of forex changes on cash | 76.03 Thousand | -17.78 Thousand | - | - | - | - |
| Net cash flow / Change in cash | -192.78 Thousand | 461.66 Thousand | 1 Million | -97.95 Thousand | -434.63 Thousand | 103.22 Thousand |
| Free Cash Flow | -268.82 Thousand | 479.44 Thousand | 1.03 Million | 100.00 | -173.61 Thousand | -1.41 Million |
| Breakdown | 2010 Q3 | 2010 Q2 | 2010 Q1 | 2009 FY | 2009 Q4 | 2009 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -627.23 Thousand | -811.21 Thousand | -549.04 Thousand | -140.74 Thousand | -386.38 Thousand | 114.8 Thousand |
| Depreciation & Amortization | 37.68 Thousand | 37.68 Thousand | 37.68 Thousand | 150.72 Thousand | 25.94 Thousand | 41.12 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 47.71 Thousand | 64.56 Thousand | 5057.00 | 2.09 Million | 1.57 Million | -973.31 Thousand |
| Other non-cash items | -168.74 Thousand | 419.19 Thousand | 493.64 Thousand | -2.2 Million | -1.88 Million | 127.64 Thousand |
| Investing Cash Flow | -1.00 | -7112.00 | - | -171.77 Thousand | 24.08 Thousand | 1.09 Million |
| Investments in PPE | - | -7461.00 | - | -171.77 Thousand | 24.08 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 349.00 | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | 1.04 Million | 31.67 Thousand | 1.19 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | 2.39 Million | -1.00 | 39.62 Thousand |
| Other working capital | - | - | - | -1.34 Million | 1.53 Million | -2.2 Million |
| Cash at beginning of period | 977.38 Thousand | 1.27 Million | 1.29 Million | 1.48 Million | 1.92 Million | 1.52 Million |
| Cash at end of period | 269.29 Thousand | 977.38 Thousand | 1.27 Million | 1.29 Million | 1.29 Million | 1.92 Million |
| Capital Expenditure | - | -7461.00 | - | -171.77 Thousand | 24.08 Thousand | - |
| Effect of forex changes on cash | 2502.00 | -1929.00 | -6360.00 | 76.03 Thousand | 18.66 Thousand | -8716.00 |
| Net cash flow / Change in cash | -708.09 Thousand | -298.81 Thousand | -19.02 Thousand | -192.78 Thousand | -626.21 Thousand | 395.16 Thousand |
| Free Cash Flow | -710.59 Thousand | -297.23 Thousand | -12.66 Thousand | -268.82 Thousand | -644.88 Thousand | -689.74 Thousand |
002389
FUPBY
ML
002955
TITAGARH
NIND